Data vendors hold key to Measurisk survival

Measurisk, a US-based risk technology provider to buy-side community, is scrambling to secure cheaper new contracts from its data vendors in a last-ditch effort to remain a viable business concern. If it can’t convince these vendors to lower their prices within the next two weeks, the company is set to enter receivership.

Measurisk was set up to offer risk reporting services to the buy-side community in January 1999. Its initial backers included Morgan Stanley, Bank of Bermuda, insurer XL Capital and US commission broker Miller Tabak. It acts as an independent provider of sophisticated financial analytics for quantifying portfolio risks for fund of funds, corporate treasuries, plan sponsors, money managers, endowments and insurers.

While risk reporting has become a critical issue for many of these companies

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here